Roquinimex

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51201800
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51201818

This classification denotes an immunostimulant and angiogenesis activator inhibitor with the molecular formula C18H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 372T2944C0, chemically known as 1,2-dihydro-4-hydroxy-n,1-dimethyl-2-oxo-3-quinolinecarboxanilide but generally known as roquinimex, which bears US NIH Compound Identifier 55197. European Medicines Agency schedules Roquinimex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10384MIG. The term ROQUINIMEX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules roquinimex in its Anatomical Therapeutic Chemical (ATC) Classification. ROQUINIMEX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roquinimex under HS 29337900 and SITC 51561. As of Q4 2014, ROQUINIMEX remains the US FDA Preferred Term for this commodity. Roquinimex bears US NLM identifiers UMLS ID C0244748 and NCI Concept Code C1519. SMILES: OC1N(C2C(C(=O)C1C(=O)N(C1CCCCC1)C)CCCC2)C.

Same parent

Under 51201800 · 28

51201801 Bacterial immunoglobulins Commodity 51201802 Filgrastim Commodity 51201803 Pegfilgrastim Commodity 51201805 Rho D immunoglobulins Commodity 51201806 Gamma IGG or immunoglobulin Commodity 51201808 Levamisole or tetramisole Commodity 51201810 Galsulfase Commodity 51201811 Thalidomide Commodity 51201812 Mifamurtide Commodity 51201813 Betazole Commodity 51201814 Bropirimine Commodity 51201815 Histamine Commodity 51201816 Impromidine Commodity 51201817 Pidotimod Commodity 51201818 Roquinimex You are here 51201819 Sargramostim Commodity 51201820 Thymopentin Commodity 51201821 Tiprotimod Commodity 51201822 Ancestim Commodity 51201823 Molgramostim Commodity 51201824 Betazole dihydrochloride Commodity 51201825 Betazole hydrochloride Commodity 51201826 Impromidine hydrochloride Commodity 51201827 Levamisole hydrochloride Commodity 51201828 Levamisole phosphate Commodity 51201829 Tetramisole hydrochloride Commodity 51201830 Pegademase Commodity 51201831 Lipegfilgrastim Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.